The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women

References

• Haffner S M, Valdez R A, Hazuda H P, Mitchell B D, Morales P A, Stern M P. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41: 715–722
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689
   PubMed Web of Science ®Google Scholar
• Trevisan M, Liu J, Bahsas F B, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998; 148: 958–966
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. WHO, Geneva 1999, (document WHO/NCD/NCS/99.2)
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486–2497
   PubMed Web of Science ®Google Scholar
• Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359
   PubMed Web of Science ®Google Scholar
• Carr M C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404–2411
   PubMed Web of Science ®Google Scholar
• Hurd W W, Barhan S M, Rogers R E. Obstetrician-gynecologist as primary care provider. Am J Manag Care 2001, 7 Spec No:SP19–24
   PubMed Web of Science ®Google Scholar
• Brett K M, Chong Y. Hormone Replacement Therapy: Knowledge and Use in the United States. National Center for Health Statistics, Hyattsville, Maryland 2001
   Google Scholar
• Ninomiya J K, L'Italien G, Criqui M H, Whyte J L, GaMetst A, Chen R S. Association of the metabolic syndrome with history of myocardial infarction and stroke in The Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42–46
   PubMed Web of Science ®Google Scholar
• Santos A C, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol 2004; 23: 45–52
   PubMedGoogle Scholar
• Aguilar-Salinas C A, Rojas R, Gomez-Perez F J, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004; 35: 76–81
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud (República de Chile). Pontificia Universidad Católica de Chile. Universidad de Chile. Encuesta Nacional de Salud Chile 2003, http://www.emol.com/noticias/documentos/informe_salud.pdf (accessed Feb 2006)
   Google Scholar
• Son le N T, Kunii D, Hung N T, Sakai T, Yamamoto S. The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res Clin Pract 2005; 67: 243–250
   PubMed Web of Science ®Google Scholar
• Thomas G N, Ho S Y, Janus E D, Lam K S, Hedley A J, Lam T H, Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005; 67: 251–257
   PubMed Web of Science ®Google Scholar
• Al-Nozha M, Al-Khadra A, Arafah M R, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26: 1918–1925
   PubMed Web of Science ®Google Scholar
• Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29–37
   PubMed Web of Science ®Google Scholar
• Athyros V G, Bouloukos V I, Pehlivanidis A N, et al. MetS-Greece Collaborative Group. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005; 7: 397–405
   PubMed Web of Science ®Google Scholar
• Gupta R, Deedwania P C, Gupta A, Rastogi S, Panwar R B, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97: 257–261
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. IDF, Brussels 2005, Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf (accessed May 2005)
   Google Scholar
• Ford E S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745–2749
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 2005; 181: 381–388
   PubMed Web of Science ®Google Scholar
• Park Y W, Zhu S, Palaniappan L, Heshka S, Carnethon M R, HeyMetsfield S B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003; 163: 427–436
   PubMed Web of Science ®Google Scholar
• Mesch V R, Boero L E, Siseles N O, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006; 9: 40–48
   PubMed Web of Science ®Google Scholar
• Ford E S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769–1778
   PubMed Web of Science ®Google Scholar
• Najarian R M, Sullivan L M, Kannel W B, Wilson P W, D'Agostino R B, Wolf P A. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006; 166: 106–111
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson J G, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350
   PubMed Web of Science ®Google Scholar